Provided by Tiger Trade Technology Pte. Ltd.

ResMed

225.99
-1.4200-0.62%
Post-market: 228.112.12+0.94%19:12 EDT
Volume:1.16M
Turnover:262.63M
Market Cap:32.99B
PE:22.35
High:227.45
Open:225.46
Low:224.78
Close:227.41
52wk High:293.81
52wk Low:199.92
Shares:145.97M
Float Shares:145.51M
Volume Ratio:1.12
T/O Rate:0.80%
Dividend:2.33
Dividend Rate:1.03%
EPS(TTM):10.11
EPS(LYR):9.55
ROE:25.68%
ROA:14.75%
PB:5.22
PE(LYR):23.67

Loading ...

Resmed Inc-144 Report of Proposed Sale of Securities

THOMSON REUTERS
·
Dec 10, 2025

144 Report of proposed sale of securities-RMD.N

Reuters
·
Dec 10, 2025

ResMed Inc. Chairman and CEO Michael J. Farrell Reports Disposal of Common Shares

Reuters
·
Dec 10, 2025

My RMD starts next year. Should I convert my whole IRA to a Roth?

Dow Jones
·
Dec 09, 2025

ResMed Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Dec 09, 2025

ResMed Secures FDA Clearance for AI-Enabled Smart Comfort CPAP Device

Reuters
·
Dec 08, 2025

Resmed Inc - Smart Comfort to Launch in Early 2026 in Limited U.S. Beta Version

THOMSON REUTERS
·
Dec 08, 2025

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to Be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize Cpap Therapy

THOMSON REUTERS
·
Dec 08, 2025

ResMed Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Dec 06, 2025

Resmed Inc-4 Statement of Changes in Beneficial Ownership

THOMSON REUTERS
·
Dec 05, 2025

4 Statement of changes in beneficial ownership-RMD.N

Reuters
·
Dec 05, 2025

Resmed Inc-144 Report of Proposed Sale of Securities

THOMSON REUTERS
·
Dec 05, 2025

ResMed Director Peter C. Farrell Reports Sale of Common Shares

Reuters
·
Dec 05, 2025

If you're over 70, you might have missed this key tax break on Giving Tuesday

Dow Jones
·
Dec 05, 2025

Should Goldman’s Conviction List Exit and New Stock Plans Require Action From ResMed (RMD) Investors?

Simply Wall St.
·
Dec 03, 2025

ResMed Inc. Global General Counsel Michael J. Rider Reports Disposal of Common Shares

Reuters
·
Dec 03, 2025

144 Report of proposed sale of securities-RMD.N

Reuters
·
Dec 03, 2025

ResMed CFO Brett Sandercock Reports Disposal of Common Shares

Reuters
·
Dec 03, 2025

LivaNova Names Lucile Blaise Global Head of Commercialization for Obstructive Sleep Apnea

Reuters
·
Dec 02, 2025

ResMed Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Dec 02, 2025